Clinical Trial

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-center, single-arm, open-label clinical study, to explore the efficacy and safety of abemaciclib combined with FOLFOX/FOLFIRI regimen in patients with advanced colorectal liver metastases cancer who failed standard two or three-line therapy.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-04-28
notable Primary completion pushed: 2027-02-28 -> 2027-04-30 2026-04-28
minor Completion pushed: 2027-02-28 -> 2027-04-30 2026-04-28
Trial Details
NCT Number NCT07441369
Lead Sponsor Fudan University
Collaborators: Shanghai Cancer Hospital, China
Conditions Liver Metastases From Colorectal Cancer (mCRC)
Enrollment 16 participants
Start Date 2026-07-30
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22